Provided by Tiger Trade Technology Pte. Ltd.

PROTEOMICS INTERNATIONAL LAB

0.360
+0.0051.41%
Volume:477.34K
Turnover:165.17K
Market Cap:59.44M
PE:-5.96
High:0.360
Open:0.350
Low:0.330
Close:0.355
52wk High:0.860
52wk Low:0.285
Shares:165.12M
Float Shares:121.55M
Volume Ratio:4.52
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.060
EPS(LYR):-0.060
ROE:-73.41%
ROA:-40.28%
PB:4.51
PE(LYR):-5.96

Loading ...

Company Profile

Company Name:
PROTEOMICS INTERNATIONAL LAB
Exchange:
ASX
Establishment Date:
2001
Employees:
- -
Office Location:
QEII Medical Centre,QQ Block,6 Verdun Street,Nedlands,Perth,Western Australia,Australia
Zip Code:
6009
Fax:
- -
Introduction:
Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research, analytical, and consultancy. Proteomics International Laboratories Ltd has a research agreement with the Busselton Population Medical Research Institute to enhance diagnosis and treatment of lung conditions, such as asthma and chronic obstructive pulmonary disease; and the Janssen Research & Development, LLC for the research of diabetic kidney and heart disease treatment. The company was founded in 2001 and is based in Perth, Australia.